Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

While patients with type 2 diabetes mellitus (T2DM) are at increased risk to develop atrial fibrillation (AF), the mechanistic link between T2DM and AF-susceptibility remains unclear. Common co-morbidities of T2DM, particularly hypertension, may drive AF in the setting of T2DM. But direct mechanisms...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Main Authors: Yurista, Salva R., Silljé, Herman H. W., Rienstra, Michiel, de Boer, Rudolf A., Westenbrink, B. Daan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Commentary
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945755/
https://ncbi.nlm.nih.gov/pubmed/31910841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0984-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares